Ensign Group Posts Q3 EPS of $1.76, Up 23.9% Year Over Year
ENSG sits 18% above its 52-week low of $141.58 on elevated volume (2.0× avg).
Summary
Ensign reported third-quarter diluted EPS of $1.76, up 23.9% from a year earlier, on revenue of $1.48 billion (+14.5%), with adjusted EPS of $2.03 and net income of $104.3 million. The company guided full-year EPS to $7.94 to $8.02 and full-year revenue to $5.89 billion. The results landed alongside the 10-Q filed minutes earlier, which also formally disclosed a new securities class action filed October 8, 2026 — the suit alleges neglect issues and followed an 8% share drop. That legal overhang is the counterweight to otherwise solid growth: the company is still spending heavily on acquisitions, including the October 2 Florida expansion. The stock trades near $167 with a roughly $9.9 billion market cap, so a double-digit EPS gain is meaningful but not thesis-changing on its own; the lawsuit disclosure is the item that could cap any relief rally.
At the time of this announcement, ENSG was trading at $167.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.9B. The 52-week trading range was $141.58 to $218.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.